Novel actions of the potassium channel modulator SDZ PCO 400 on ATP-regulated potassium channels in insulin secreting cells. SDZ PCO 400 and beta-cells.
Harding
E A
EA
Department of Biomedical Science, Sheffield, United Kingdom.
Dunne
M J
MJ
D000255:Adenosine Triphosphate / Q000494:pharmacology*; D000818:Animals; D001578:Benzopyrans / Q000494:pharmacology*; D002460:Cell Line; D002478:Cells, Cultured; D003517:Cyclopentanes / Q000494:pharmacology*; D006146:Guanidines / Q000494:pharmacology; D015640:Ion Channel Gating; D007515:Islets of Langerhans / Q000187:drug effects / Q000502:physiology*; D008297:Male; D008564:Membrane Potentials / Q000187:drug effects / Q000502:physiology; D018408:Patch-Clamp Techniques; D010646:Phentolamine / Q000494:pharmacology; D020110:Pinacidil; D015221:Potassium Channels / Q000187:drug effects / Q000502:physiology*; D051381:Rats; D017208:Rats, Wistar
D001578:Benzopyrans; D003517:Cyclopentanes; D006146:Guanidines; D015221:Potassium Channels; C073091:SDZ PCO 400; D020110:Pinacidil; D000255:Adenosine Triphosphate; D010646:Phentolamine